Go Pro

Ascendis Pharma A/S (ASND) News Today

Ascendis Pharma A/S logo
$270.56 -0.56 (-0.21%)
As of 09/4/2026 04:00 PM Eastern

Ascendis Pharma A/S Latest News

Sapient Capital LLC Takes Position in Ascendis Pharma A/S $ASND
HC Wainwright Has Positive Outlook for ASND FY2026 Earnings
Best Growth Stocks To Watch Now - August 31st
Wedbush Reiterates "Outperform" Rating for Ascendis Pharma A/S (NASDAQ:ASND)
HC Wainwright Brokers Decrease Earnings Estimates for ASND
HC Wainwright Has Positive Forecast for ASND FY2026 Earnings
HC Wainwright Has Negative Outlook for ASND Q3 Earnings
Ascendis Pharma Earnings Call Highlights Blockbuster Momentum
Ascendis Pharma (ASND) Receives a Buy from Morgan Stanley
Ascendis Pharma (ASND) Q2 2026 Earnings Call Transcript
Ascendis Pharma's Q2 Adjusted Earnings, Revenue Rise
Ascendis Pharma A/S Q2 Earnings Call Highlights

Ascendis Pharma A/S Media Mentions By Week

Ascendis Pharma A/S Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

ASND
News Sentiment

0.57

0.77

Average
Healthcare
News Sentiment

Ascendis Pharma A/S News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

ASND Articles
This Week

44

6

ASND Articles
Average Week

Ascendis Pharma A/S Trends on MarketBeat

This week vs. last week
New Followers
1
-50%
Searches
7
+600%
Page Views
3,141
+1%
Get Ascendis Pharma A/S News Delivered to You Automatically

Sign up to receive the latest news and ratings for ASND and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Related Companies and Tools


MarketBeat tracks news from more than one hundred trusted media outlets in real time, with the most recent headline for Ascendis Pharma A/S dated 9/4/2026.
From Our Partners